US Pharmaceutical CDMO Market Trends, Growth and Market Size Analysis 2035
The global U.S. pharmaceutical CDMO market size was estimated at USD 39.13 billion in 2025 and is predicted to increase from USD 41.65 billion in 2026 to approximately USD 72.98 billion by 2035, expanding at a CAGR of 6.43% from 2026 to 2035. Our senior research analyst Payal Rabade, with her extensive experience in healthcare, indicates exponential market growth due to increasing outsourcing of pharmaceutical manufacturing, expansion of biologics production, rising adoption of advanced manufacturing technologies, and the need to reduce development costs and accelerate time to market.
Last Updated : 23 September 2026
Category: Healthcare Services
Insight Code: 5407
Format: PDF / PPT / Excel